Paradoxical manifestation is common in HIV-negative tuberculous meningitis

Medicine (United States)

Volumn 95, Issue 1, 2016, Pages

  Tai, Mei Ling Sharon ^a   Nor, Hazman Mohd ^a   Kadir, Khairul Azmi Abdul ^a   Viswanathan, Shanthi ^b   Rahmat, Kartini ^a   Zain, Norzaini Rose Mohd ^c   Ong, Kuo Ghee ^a   Rafia, Mohd Hanip ^b   Tan, Chong Tin ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Department of Neurology ^*  (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BRAIN INFARCTION; BRAIN VASCULITIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DETERIORATION; FEMALE; FEVER; FOLLOW UP; HEADACHE; HIV NEGATIVE TUBERCULOUS MENINGITIS; HUMAN; HYDROCEPHALUS; INTRACRANIAL TUBERCULOMA; LOSS OF APPETITE; MAGNETIC RESONANCE ANGIOGRAPHY; MAINTENANCE THERAPY; MALE; NEUROIMAGING; NEUROLOGICAL COMPLICATION; PARADOXICAL MANIFESTATION; PLEOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RECURRENT DISEASE; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULOUS MENINGITIS; VOMITING; WEIGHT REDUCTION; BRAIN; BRAIN ANGIOGRAPHY; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE COURSE; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SERODIAGNOSIS; TUBERCULOSIS, MENINGEAL; X-RAY COMPUTED TOMOGRAPHY;

ADULT; ANTITUBERCULAR AGENTS; BRAIN; CEREBRAL ANGIOGRAPHY; DISEASE PROGRESSION; FEMALE; HIV SERONEGATIVITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, MENINGEAL;

EID: 84955247974     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001997     Document Type: Article

References (23)

1. Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J Neurol Sci. 2011;303:22-30.
2. de Castro CC, de Barros NG, Campos ZM, et al. CT scans of cranial tuberculosis. Radiol Clin North Am. 1995;33:753-769.
3. Ravindra Kumar Garg, Hardeep Singh Malhotra, Neeraj Kumar. Paradoxical reaction in HIV negative tuberculous meningitis. J Neurol Sci. 2014;340:26-36.
4. Sütlas PN, Unal A, Forta H, et al. Tuberculous meningitis in adults: review of 61 cases. Infection. 2003;31:387-391.
5. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741-1751.
6. Raut T, Garg RK, Jain A, et al. Hydrocephalus in tuberculous meningitis: incidence, its predictive factors and impact on the prognosis. J Infect. 2013;66:330-337.
7. Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59: 167-187.
8. Treatment of tuberculosis:guidelines-Index of-World Health Organisation. Fourth Edition. http://apps.who.int/iris/bitstream/10665/44165/1/9789241547833-eng.pdf.
9. Carvalho AC, De Iaco G, Saleri N, et al. Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients. Clin Infect Dis. 2006;42:893-895.
10. Lorent N, Sebatunzi O, Mukeshimana G, et al. Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study. PLoS One. 2011;6:e19566.
11. Cheng VC, Yam WC, Woo PC, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2003;22:597-602.
12. Geri G, Passeron A, Heym B, et al. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV negative patients. Infection. 2013;41:537-543.
13. Anuradha HK, Garg RK, Agarwal A, Sinha MK, Verma R, Singh MK, et al. Predictors of stroke in patients with tuberculous meningitis and its effect on the outcome. Q J Med. 2010;103: 671-678.
14. Teoh R, O'Mahony G, Yeung VT. Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis. J Neurol. 1986;233:237-241.
15. Singh B, Garg RK, Singh MK, et al. Computed tomography angiography in patients with tuberculous meningitis. J Infect. 2012;64:565-572.
16. Schoeman JF, Donald PR. Tuberculous meningitis. Handb Clin Neurol. 2013;112:1135-1138.
17. Coulter JB, Baretto RL, Mallucci CL, et al. Interferon gamma. Lancet Infect Dis. 2007;7:225-232.
18. Unal A, Suflas PN. Clinical and radiological features of symptomatic central nervous system tuberculomas. Eur J Neurol. 2005;12:797-804.
19. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis. 1994;19:1092-1099.
20. Kim SH, Kim YS. Immunologic paradox in the diagnosis of tuberculous meningitis. Clin Vaccine Immunol. 2009;16:1847-1849.
21. Sáenz B, Hernandez-Pando R, Fragoso G, et al. The dual face of central nervous system tuberculosis: a new Janus Bifrons? Tuberculosis (Edinb). 2013;93:130-135.
22. Hawkey CR, Yap T, Pereira J, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis. 2005;40:1368-1371.
23. Bekker LG, Maartens G, Steyn L, et al. Selective increase in plasma tumour necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis. 1998;178:580-584.